The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions. Against this backdrop Drug Discovery 2017 will provide a platform to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.
The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include
Plus more from AbbVie, UCB Pharma, Eli Lilly, TissUse, Heptares etc.
For more information and to register, kindly visit http://www.drug-discovery.co.uk/euagenda.
27 March 2017 @ 08:30
28 March 2017 @ 05:30
Duration: 1 days, 9 hours
Holiday Inn Kensington Forum
97 Cromwell Rd
SMi Group Ltd. (view profile)